Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

GW24-e3174 A trial overexpression of ACE2 improves the canine rapid atrial pacing-induced structural remodelling

View through CrossRef
Objectives Atrial fibrillation (AF) is associated with significant morbidity and mortality. Substantial evidence suggests that the renin angiotensin system (RAS) has a role in the pathogenesis of AF. Angiotensin-converting enzyme 2 (ACE2), a monocarboxypeptidase capable of metabolising angiotensin II (Ang II) into angiotensin-(1-7) [Ang-(1-7)], has emerged as a potential therapeutic target. The purpose of this study was to investigate whether atrial overexpression of ACE2 by homogeneous transmural atrial gene transfer can reverse AF induced atrial remodelling and their mechanisms in a canine atrial pacing model. Methods Twenty-eight mongrel dogs were randomly divided into 4 groups: Sham-operated, control, gene therapy with Ad-EGFP (adenovirus-enhanced green fluorescent protein) and gene therapy with Ad-ACE2 (Ad-ACE2 group) (n = 7 per subgroup). Sustained AF was induced in all dogs besides Sham-operated group by atrial rapid pacing at 450 beats/min for 2 weeks. All dogs underwent an invasive electrophysiology study, then receveid epicardial gene painting. Three weeks after gene transfer, all animals underwent repeat electrophysiology study, histology, and molecular studies. Results The Ad-ACE2 group showed increased ACE2, Angiotensin-(1-7) and AT2R expression, and decreased Angiotensin II and AT1R expression in comparison with Ad-EGFP and control groups. ACE2 overexpression attenuated atrial tachypacing induced increase in the levels of activated extracellular signal-regulated kinases (ERK1/2) and mitogen-activated protein kinases (p38MAPK), and decrease in the levels of MAPK phosphatase 1, resulting in attenuation of atrial fibrosis marker, collagen protein and transforming growth factor-β1. Additionally, ACE2 overexpression also ameliorated tachypacing-induced up regulation of connexin 40 and down regulation of connexin 43, Cav1.2 and Kv4.2, and significantly decreased the inducibility and duration of AF. Conclusions ACE2 overexpression could shift the RAS balance towards the protective axis, attenuate cardiac fibrosis remodelling associated with up-regulation of MKP-1 to reduce MAPK activities, ameliorate tachypacing-induced ion channel and connexin remodelling, and subsequently reduce the inducibility and duration of AF. Therefore, overexpression of ACE2 by homogeneous transmural atrial gene transfer could improve atria electrical and structural remodelling in a canine atrial pacing model.
Title: GW24-e3174 A trial overexpression of ACE2 improves the canine rapid atrial pacing-induced structural remodelling
Description:
Objectives Atrial fibrillation (AF) is associated with significant morbidity and mortality.
Substantial evidence suggests that the renin angiotensin system (RAS) has a role in the pathogenesis of AF.
Angiotensin-converting enzyme 2 (ACE2), a monocarboxypeptidase capable of metabolising angiotensin II (Ang II) into angiotensin-(1-7) [Ang-(1-7)], has emerged as a potential therapeutic target.
The purpose of this study was to investigate whether atrial overexpression of ACE2 by homogeneous transmural atrial gene transfer can reverse AF induced atrial remodelling and their mechanisms in a canine atrial pacing model.
Methods Twenty-eight mongrel dogs were randomly divided into 4 groups: Sham-operated, control, gene therapy with Ad-EGFP (adenovirus-enhanced green fluorescent protein) and gene therapy with Ad-ACE2 (Ad-ACE2 group) (n = 7 per subgroup).
Sustained AF was induced in all dogs besides Sham-operated group by atrial rapid pacing at 450 beats/min for 2 weeks.
All dogs underwent an invasive electrophysiology study, then receveid epicardial gene painting.
Three weeks after gene transfer, all animals underwent repeat electrophysiology study, histology, and molecular studies.
Results The Ad-ACE2 group showed increased ACE2, Angiotensin-(1-7) and AT2R expression, and decreased Angiotensin II and AT1R expression in comparison with Ad-EGFP and control groups.
ACE2 overexpression attenuated atrial tachypacing induced increase in the levels of activated extracellular signal-regulated kinases (ERK1/2) and mitogen-activated protein kinases (p38MAPK), and decrease in the levels of MAPK phosphatase 1, resulting in attenuation of atrial fibrosis marker, collagen protein and transforming growth factor-β1.
Additionally, ACE2 overexpression also ameliorated tachypacing-induced up regulation of connexin 40 and down regulation of connexin 43, Cav1.
2 and Kv4.
2, and significantly decreased the inducibility and duration of AF.
Conclusions ACE2 overexpression could shift the RAS balance towards the protective axis, attenuate cardiac fibrosis remodelling associated with up-regulation of MKP-1 to reduce MAPK activities, ameliorate tachypacing-induced ion channel and connexin remodelling, and subsequently reduce the inducibility and duration of AF.
Therefore, overexpression of ACE2 by homogeneous transmural atrial gene transfer could improve atria electrical and structural remodelling in a canine atrial pacing model.

Related Results

GW24-e1111 The effects of ACE2 on RAS system by painting on epicadial in atrial rapid pacing canine
GW24-e1111 The effects of ACE2 on RAS system by painting on epicadial in atrial rapid pacing canine
Objectives To study the effects of ACE2 on RAS system in rapid atrial pacing canine, and to investigate the possible mechanisms of ACE2 in improving atrial fibril...
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Abstract ACE2, a member of the angiotensin converting enzyme family, plays an irreplaceable role in the renin-angiotensin system. And the variations of ACE2 are regarded as...
Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
AbstractCOVID-19 is a highly infectious respiratory disease caused by the novel coronavirus SARS-CoV-2. It has become a global pandemic and its frequent mutations may pose new chal...
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
Abstract Background Atrial arrhythmias represent a major cause of morbidity and hospitalization in patients with atrial septal d...
Acute Changes in Cardiac Synchrony and Output According to RV Pacing Sites in Koreans with Normal Cardiac Function
Acute Changes in Cardiac Synchrony and Output According to RV Pacing Sites in Koreans with Normal Cardiac Function
Introduction: The synchrony of the pacing heart can be affected by the right ventricular (RV) pacing site and is crucial to cardiac function in pacemaker recipients. We evaluated t...
Changes in pacing variation with increasing race duration in ultra-triathlon races
Changes in pacing variation with increasing race duration in ultra-triathlon races
Abstract Background: Despite the increasing scientific interest in the relationship between pacing and performance in endurance sports, little information is available abou...
Long‐Term Follow‐up Impact of Dual‐Chamber Pacing on Patients with Hypertrophic Obstructive Cardiomyopathy
Long‐Term Follow‐up Impact of Dual‐Chamber Pacing on Patients with Hypertrophic Obstructive Cardiomyopathy
BackgroundPacing has been proposed as a treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM), but there are few studies with long‐term follow‐up. We evaluated...

Back to Top